Longitude Capital Partners, LLC's Net Worth
$0
Estimate Recalculated Nov 7, 2024 11:40AM EST
Who is Longitude Capital Partners, LLC?
Longitude Capital Partners, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, COLLEGIUM PHARMACEUTICAL, INC, and Esperion Therapeutics, Inc..
SEC CIK
Longitude Capital Partners, LLC's CIK is 0001430720
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $37.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.10% | -1.00M |
$17.34 | -$17,340,000.00 | 2.32M |
Dec 8
| |||
Form 4
|
∞
| 3.32M |
$12.00 |
—
| 3.32M |
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CORCEPT THERAPEUTICS INC (CORT) Snapshot price: $34.38
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -21.50% | -3.00M |
—
|
—
| 10.96M |
Nov 28
| |||
Form 4
| -0.26% | -36.94K |
$9.34 | -$345,165.30 | 13.96M |
Nov 22 - Nov 25
| |||
Form 4
| -3.74% | -544.10K |
$9.56 | -$5,199,426.22 | 13.99M |
Nov 17 - Nov 21
| |||
Form 4
| -1.19% | -174.85K |
$9.55 | -$1,669,605.81 | 14.54M |
Nov 15 - Nov 16
| |||
Form 4
| +6.18% | 856.64K |
$4.05 | $3,469,408.20 | 14.71M |
Mar 30
| |||
Form 4
| +9.24% | 1.17M |
$4.29 | -$10.79 | 13.86M |
Mar 20 - Mar 24
| |||
Form 4
| -0.97% | -250.00K |
$4.10 | -$1,026,569.45 | 25.45M |
May 1 - May 2
| |||
Form 4
| -1.90% | -250.00K |
$4.28 | -$1,070,575.00 | 12.93M |
Apr 1
| |||
Form 4
| -0.63% | -250.00K |
$4.00 | -$1,000,818.05 | 39.74M |
Mar 5 - Mar 7
| |||
Form 4
| +6.81% | 856.64K |
$2.96 | $2,535,666.24 | 13.43M |
Mar 29
| |||
Form 4
| +6.34% | 750K |
$3.90 | $2,925,000.00 | 12.58M |
Jan 21
| |||
Form 4
| +7.81% | 856.64K |
$1.66 | $1,422,029.04 | 11.83M |
Apr 21
| |||
Form 4
| +28.72% | 2.45M |
$1.38 | $3,377,623.14 | 10.97M |
Oct 16
| |||
Form 4
| +119.67% | 4.64M |
$0.69 | $3,189,642.76 | 8.52M |
Feb 6
| |||
Form 4
| +9.90% | 349.43K |
$1.45 | $506,666.25 | 3.88M |
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -25.35% | -487.13K |
$32.78 | -$15,966,168.16 | 1.43M |
Nov 17 - Nov 18
| |||
Form 4
| -0.05% | -943.00 |
$30.00 | -$28,290.00 | 1.92M |
Oct 9
| |||
Form 4
| -0.62% | -11.93K |
$30.04 | -$358,289.49 | 1.92M |
Oct 7
| |||
Form 4
|
∞
| 1.93M |
$14.00 |
—
| 1.93M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||